Benton Chuter, None;
Mark Christopher, National Eye Institute (F);
Rui Fan, None;
Akram Belghith, None;
Christopher Bowd, None;
Nicole Brye, None;
James Proudfoot, None;
Jasmin Rezapour, German Ophthalmological Society (DOG) grant (F), Research fellowship grant of the German Research Foundation (DFG) (RE4155/1-1) (F);
Massimo Fazio, EyeSight Foundation of Alabama (F), Heidelberg Engineering GmbH (F), National Eye Institute (F), Research to Prevent Blindness (F);
Michael Goldbaum, None;
Robert Weinreb, Aerie Pharmaceuticals (C), Allergan (C), Bausch&Lomb (C), Carl Zeiss Meditec (F), Centervue (F), Eyenovia (C), Heidelberg Engineering (F), Konan Medical (F), Meditec-Zeiss (P), Optovue (F), Toromedes (P);
Christopher Girkin, EyeSight Foundation of Alabama (F), Heidelberg Engineering GmbH (F), National Eye Institute (F), Research to Prevent Blindness (F);
Jeffrey Liebmann, Aerie (C), Alcon (C), Allergan (C), Bausch & Lomb (C), Bausch & Lomb (F), Carl Zeiss Meditec (C), Eyenova (C), Galimedex (C), Heidelberg Engineering (F), Heidelberg Engineering GmbH (C), National Eye Institute (F), Novartis (C), Optovue (F), Reichert (C), Reichert (F), Research to Prevent Blindness (F), Topcon (F), Valeant Pharmaceuticals (C);
C Gustavo De Moraes, Belite (C), Carl Zeiss Meditec (C), Galimedix (C), Heidelberg (R), Novartis (C), Perfuse Therapeutics (C), Reichert (C), Topcon (R);
Linda Zangwill, Carl Zeiss Meditec (F), Heidelberg Engineering (R), Heidelberg Engineering GmbH (F), Meditec-Zeiss (P), National Eye Institute (F), Optovue (F), Topcon Medical Systems (F)